Day 1 – Sept 23, 2026Wednesday, September 23, 2026 - ET (Eastern Time, GMT-05:00)

Identifying high-growth regions and market opportunities

Navigating regulatory landscapes and compliance challenges

Building strategic partnerships to accelerate market entry

How prioritizing IPOs, M&A, or revenue, changes governance, hiring, and program selection compared with goals like platform enablement, open science, or measurable patient outcomes

Examining how investor horizons, deal structures and funding mixes shape R&D priorities and whether they align or conflict with longterm societal goals

Access vs. scale: does commercialization reliably increase patient access or create affordability barriers?

Navigating limited patient populations and high development costs

Building awareness and education among healthcare providers

Leveraging orphan drug incentives and regulatory support

Managing supply chain complexities and ensuring scalability

Aligning cross-functional teams for seamless execution

Balancing cost efficiency with quality and compliance